[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condbio:heart-failure:n-terminal-fragment-brain-natriuretic-protein":3},{"condition":4,"biomarker":5,"total":6,"trials":7},"Heart Failure","N-Terminal Fragment Brain Natriuretic Protein",13,[8,16,23,29,36,42,49,55,61,67,74,81,87],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT06183437","The STOP-MED CTRCD Trial",[12],"Phase 4","RECRUITING","2026-08-26T02:19:23.493898Z","2026-07-19T19:36:05.127136Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT06130059","Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation",[20],"Phase 2","2026-08-26T02:17:58.890423Z","2026-05-05T02:43:29.468583Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07232030","Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure",[],"2026-08-26T02:18:39.640967Z","2026-05-05T02:43:28.794388Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":34,"content_modified":35},"NCT07547540","A Study of LY3971297 in Participants With Heart Failure",[33],"Phase 1","2026-08-26T02:19:14.560989Z","2026-05-05T02:43:27.989410Z",{"nct_id":37,"title":38,"phases":39,"status":13,"updated_at":40,"content_modified":41},"NCT06979362","A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy",[20],"2026-08-26T02:18:00.873391Z","2026-05-05T02:43:27.633319Z",{"nct_id":43,"title":44,"phases":45,"status":13,"updated_at":47,"content_modified":48},"NCT07188805","A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic Dysfunction",[46],"Phase 3","2026-08-26T02:15:31.806698Z","2026-05-05T02:43:27.598389Z",{"nct_id":50,"title":51,"phases":52,"status":13,"updated_at":53,"content_modified":54},"NCT06147336","A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System",[],"2026-08-26T02:15:42.447052Z","2026-05-05T02:43:29.649892Z",{"nct_id":56,"title":57,"phases":58,"status":13,"updated_at":59,"content_modified":60},"NCT06675448","In Search of Best Practices for Patients With Heart Failure and Secondary Mitral Regurgitation: An Evaluation of the Inova Heart Failure Treatment Algorithm",[],"2026-08-26T02:15:28.524219Z","2026-05-13T02:55:06.563025Z",{"nct_id":62,"title":63,"phases":64,"status":13,"updated_at":65,"content_modified":66},"NCT03480633","Biomechanical Precision Medicine Registry for Patients With and Without Heart Failure",[],"2026-08-26T02:18:02.701182Z","2026-05-13T02:55:06.171777Z",{"nct_id":68,"title":69,"phases":70,"status":71,"updated_at":72,"content_modified":73},"NCT06369298","Study of JK07 in Patients With Chronic Heart Failure",[20],"ACTIVE_NOT_RECRUITING","2026-08-03T03:00:46.495174Z","2026-05-05T02:43:29.337022Z",{"nct_id":75,"title":76,"phases":77,"status":78,"updated_at":79,"content_modified":80},"NCT04160000","Treatment Of Atrial Fibrillation In Preserved Cardiac Function Heart Failure",[12],"UNKNOWN","2026-08-03T03:51:46.071131Z","2026-05-05T02:43:28.653389Z",{"nct_id":82,"title":83,"phases":84,"status":71,"updated_at":85,"content_modified":86},"NCT05636176","A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation",[46],"2026-08-03T02:15:56.082035Z","2026-05-05T02:43:27.635900Z",{"nct_id":88,"title":89,"phases":90,"status":71,"updated_at":91,"content_modified":92},"NCT06200207","A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation",[46],"2026-08-03T02:56:25.717758Z","2026-05-05T02:35:31.612750Z"]